Physician profile
Nancy A Argano
NPI 1174879191
$1,929.11
in general payments reported to CMS, 2019-2025
19 companies · $528 in 2025
The $528 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $87.05 · 2021: $327 · 2022: $286 · 2023: $141 · 2024: $378 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $324.75 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $289.78 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $241.45 | 2021-2025 | Tryptyr, Total30, Eysuvis |
| Tarsus Pharmaceuticals, INC. | $240.22 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $154.46 | 2022-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $129.83 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $124.74 | 2019-2021 | |
| Harrow Eye, LLC | $83.85 | 2024-2025 | Vevye |
| Thea Pharma INC. | $59.96 | 2023-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $52.33 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $50.17 | 2019-2022 | |
| Dompe US, INC. | $35.53 | 2022-2025 | Oxervate |
| Abbvie INC. | $33.07 | 2022-2025 | |
| Eyevance Pharmaceuticals LLC | $29.27 | 2021-2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $16.71 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $16.59 | 2022 | |
| Alcon Research LLC | $14.24 | 2019 | |
| Sight Sciences, INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Argano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.